GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Guanhao Biotech Co Ltd (SZSE:300238) » Definitions » EV-to-Revenue

Guanhao Biotech Co (SZSE:300238) EV-to-Revenue : 7.10 (As of May. 27, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Guanhao Biotech Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Guanhao Biotech Co's enterprise value is ¥2,719.3 Mil. Guanhao Biotech Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥382.9 Mil. Therefore, Guanhao Biotech Co's EV-to-Revenue for today is 7.10.

The historical rank and industry rank for Guanhao Biotech Co's EV-to-Revenue or its related term are showing as below:

SZSE:300238' s EV-to-Revenue Range Over the Past 10 Years
Min: 5.33   Med: 13.24   Max: 91.6
Current: 7.1

During the past 13 years, the highest EV-to-Revenue of Guanhao Biotech Co was 91.60. The lowest was 5.33. And the median was 13.24.

SZSE:300238's EV-to-Revenue is ranked better than
53.08% of 1038 companies
in the Biotechnology industry
Industry Median: 8.145 vs SZSE:300238: 7.10

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-27), Guanhao Biotech Co's stock price is ¥10.22. Guanhao Biotech Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1.48. Therefore, Guanhao Biotech Co's PS Ratio for today is 6.92.


Guanhao Biotech Co EV-to-Revenue Historical Data

The historical data trend for Guanhao Biotech Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guanhao Biotech Co EV-to-Revenue Chart

Guanhao Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.85 15.46 9.96 6.96 8.61

Guanhao Biotech Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.68 10.29 8.99 8.61 7.22

Competitive Comparison of Guanhao Biotech Co's EV-to-Revenue

For the Biotechnology subindustry, Guanhao Biotech Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guanhao Biotech Co's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Guanhao Biotech Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Guanhao Biotech Co's EV-to-Revenue falls into.



Guanhao Biotech Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Guanhao Biotech Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=2719.335/382.935
=7.10

Guanhao Biotech Co's current Enterprise Value is ¥2,719.3 Mil.
Guanhao Biotech Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥382.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Guanhao Biotech Co  (SZSE:300238) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Guanhao Biotech Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=10.22/1.476
=6.92

Guanhao Biotech Co's share price for today is ¥10.22.
Guanhao Biotech Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.48.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Guanhao Biotech Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Guanhao Biotech Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Guanhao Biotech Co (SZSE:300238) Business Description

Traded in Other Exchanges
N/A
Address
No.12 Yuyan Road, Luogang District, Guangdong, Guangzhou, CHN, 510530
Guanhao Biotech Co Ltd is a China-based biotech company. It develops, manufactures and markets life and health-related products, with focus on regenerative medicines for the treatment of damaged tissue and organs. Its products include NormalGEN dura repair patch, GrandNeuro (Type B) dura repair patch, ThromalGEN (Type P) surgical patch, Guanhao-ACI, among others.
Executives
Liu De Wang Directors, executives
Zhao Jun Hui Directors, executives
Yang Guo Sheng Supervisors
Zhu Wei Ping Director
Hu Jun Securities Affairs Representative
Jia Bao Rong Executives
Jia Jun Chao Executives
Di Pu Director
Zhuo Fu Min Director
Guo Xiao Ming Executives
Zhang Hong Tao Executives
Zhao Wen Jie Executives
Guan Xin Director

Guanhao Biotech Co (SZSE:300238) Headlines

No Headlines